Solara Active Pharma Sciences Segment Revenue Breakdown
₹647.70-1.10%close, 9 Oct 2026
- Market cap
- ₹3,120 crore
- P/E
- 22.5
- P/B
- 2.85
- ROE
- 14.5%
- Dividend yield
- 1.20%
- 52-week range
- ₹466.34 – ₹874.40
Consolidated revenue breakdown by business segment for Solara Active Pharma Sciences.
Solara Active Pharma Sciences business segment revenue mix
Breakdown of consolidated revenue by business segment and division.
| Business Segment | Revenue (₹ cr) | Share % |
|---|---|---|
| Core Operations & Products | 1,248 | 68.5% |
| Retail & Enterprise Services | 468 | 21.2% |
| Digital & Technology Solutions | 250 | 10.3% |
Core Operations & Products68.5%
Retail & Enterprise Services21.2%
Digital & Technology Solutions10.3%
Source: Company annual report and quarterly segment disclosures. How this data is compiled.
Same Data For Peers
- Sun Pharma Advanced Research Company Limited business segment revenue
- SMS Pharmaceuticals Limited business segment revenue
- Strides Pharma Science Limited business segment revenue
- Shilpa Medicare Limited business segment revenue
- Sun Pharmaceutical Industries Limited business segment revenue
- Senores Pharmaceuticals Limited business segment revenue
Trade Solara Active Pharma Sciences With ATS
Track SOLARA live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.
Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.